Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.440 | 9.630 | 7.190 |
Stocks | 97.580 | 97.580 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 28.929 | 30.885 |
Price to Book | 7.358 | 6.554 |
Price to Sales | 4.661 | 4.562 |
Price to Cash Flow | 19.847 | 19.209 |
Dividend Yield | 0.638 | 0.642 |
5 Years Earnings Growth | 13.677 | 14.855 |
Name | Net % | Category Average |
---|---|---|
Technology | 35.520 | 36.046 |
Consumer Cyclical | 16.730 | 13.769 |
Healthcare | 14.260 | 14.985 |
Financial Services | 14.170 | 10.489 |
Communication Services | 8.440 | 11.368 |
Industrials | 4.930 | 7.999 |
Consumer Defensive | 3.870 | 4.548 |
Energy | 2.070 | 2.148 |
Number of long holdings: 123
Number of short holdings: 197
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Amazon.com Inc | - | 7.81 | - | - | |
Microsoft Corp | - | 7.40 | - | - | |
Alphabet Inc Class C | - | 6.38 | - | - | |
Mastercard Inc Class A | - | 4.59 | - | - | |
Eli Lilly and Co | - | 4.17 | - | - | |
Apple Inc | - | 3.30 | - | - | |
Progressive Corp | - | 3.26 | - | - | |
Amphenol Corp Class A | - | 3.00 | - | - | |
Visa Inc Class A | - | 2.69 | - | - | |
Thermo Fisher Scientific Inc | - | 2.66 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pioneer US Fndmntl Growth C EUR ND | 3.09B | 9.80 | 10.64 | 14.37 | ||
PioneerFunds Euro Eq Value C EUR ND | 2.83B | 4.54 | 6.33 | 4.52 | ||
Core Series Core Champions E EUR ND | 839.75M | 2.00 | -1.21 | 2.41 | ||
Pioneer Top Euro Players H EUR ND | 668.55M | 6.19 | 6.81 | 6.16 | ||
Pioneer FundsTopEuroPlayersI EUR ND | 668.55M | 6.17 | 6.79 | 6.29 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review